| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Benzamide, 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]-2-pyrazinyl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluoro-, hydrochloride (1:) |
|
1715025-34-5 |
詳細(xì)
|
| 1H-Indole-6-carboxamide, 1-[(2-chloro-6-fluorophenyl)methyl]-2,3-dihydro-3,3-dimethyl-2-oxo-N-[(2,4,6-trifluorophenyl)methyl]- |
|
2259624-71-8 |
詳細(xì)
|
| Donepezil hydrochloride monohydrate |
|
120014-06-4 |
詳細(xì)
|
| BMS-754807 |
|
1001350-96-4 |
詳細(xì)
|
| MORIN |
|
480-16-0 |
詳細(xì)
|
| E-7386 |
|
1799824-08-0 |
詳細(xì)
|
| ZL0420 |
|
2230496-80-5 |
詳細(xì)
|
| Ramelteon |
|
196597-26-9 |
詳細(xì)
|
| 2-Pyridinecarboxamide, N-[3-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl- |
|
1262857-73-7 |
詳細(xì)
|
| Heptadecan-9-yl 8-((2-hydroxyethyl)(8-nonyloxy)-8-oxooctyl)amino)octanoate |
|
2089251-33-0 |
詳細(xì)
|
| Avatrombopag hydrochloride |
|
570403-17-7 |
詳細(xì)
|
| 7-Epitaxol |
|
105454-04-4 |
詳細(xì)
|
| AZM 475271 |
|
476159-98-5 |
詳細(xì)
|
| (+)-Blebbistatin |
|
1177356-70-5 |
詳細(xì)
|
| TES-1025 |
|
1883602-21-8 |
詳細(xì)
|
| DMG-PEG2000 |
|
160743-62-4 |
詳細(xì)
|
| 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one |
|
2170722-84-4 |
詳細(xì)
|
| Perifosine |
|
157716-52-4 |
詳細(xì)
|
| Prucalopride |
|
179474-81-8 |
詳細(xì)
|
| Ethyl α-(p-Methoxyphenyl)-β-(dimethylamino)propionate |
|
323176-93-8 |
詳細(xì)
|
| TD52 |
|
1798328-24-1 |
詳細(xì)
|
| MELK-T1(JNJ-47117096) HCl |
|
1610536-69-0 |
詳細(xì)
|
| N-(4-butylphenyl)-5-nitrofuran-2-carboxamide |
|
346691-38-1 |
詳細(xì)
|
| SPDP |
|
68181-17-9 |
詳細(xì)
|
| (R)-1-((2R, 4R, SR)-3,3-difluoro-4-hydroxy (hydroxymethyl) tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one |
|
1141397-80-9 |
詳細(xì)
|
| FMK 9a |
|
1955550-51-2 |
詳細(xì)
|
| tert-butyl 4-(7-bromo-6-chloro-8-fluoroquinazolin-4-yl)piperazine-1-carboxylate |
|
1698027-20-1 |
詳細(xì)
|
| DDD85646 |
|
1215010-55-1 |
詳細(xì)
|
| 7-MORPHOLIN-4-YL-BENZO[1,2,5]OXADIAZOL-4-YLAMINE |
|
842964-18-5 |
詳細(xì)
|
| FHD-286 |
|
2671128-05-3 |
詳細(xì)
|
| 4-[2-Amino-6-[(1R)-2,2,2-trifluoro-1-(3'-methoxy[1,1'-biphenyl]-4-yl)ethoxy]-4-pyrimidinyl]-L-phenylalanine |
|
945976-76-1 |
詳細(xì)
|
| PFK-158 |
|
1462249-75-7 |
詳細(xì)
|
| GDC-0077 |
|
2060571-02-8 |
詳細(xì)
|
| URB-597 |
|
546141-08-6 |
詳細(xì)
|
| BEAUVERICIN |
|
26048-05-5 |
詳細(xì)
|
| NF-56-EJ40 |
|
2380230-73-7 |
詳細(xì)
|
| SB 271046 |
|
209481-20-9 |
詳細(xì)
|
| Dydrogesterone |
|
152-62-5 |
詳細(xì)
|
| 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine |
|
1337962-47-6 |
詳細(xì)
|
| MELK-8a (hydrochloride) |
|
2096992-20-8 |
詳細(xì)
|
| Umibecestat |
|
1387560-01-1 |
詳細(xì)
|
| SHIN1 |
|
2146095-85-2 |
詳細(xì)
|
| Cytochalasin H |
|
53760-19-3 |
詳細(xì)
|
| Entacapone |
|
130929-57-6 |
詳細(xì)
|
| Atomoxetine hydrochloride |
|
82248-59-7 |
詳細(xì)
|
| CETRAXATE, HYDROCHLORIDE |
|
27724-96-5 |
詳細(xì)
|
| VH 032, PHENOL |
|
2244684-42-0 |
詳細(xì)
|
| Pyrido[2,3-d]pyrimidin-2(1H)-one, 7-(2-amino-6-fluorophenyl)-1-(4,6-dicyclopropyl-5-pyrimidinyl)-4-[(2S,5R)-2,5-dimethyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-6-fluoro- |
|
2559761-14-5 |
詳細(xì)
|
| L-Lysine, coMpd. with 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-1-Methyl-2-[(phosphonooxy)Methoxy]-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile and ethanol (1:1:1) (9CI) |
|
914361-45-8 |
詳細(xì)
|
| SPD-304 |
|
869998-49-2 |
詳細(xì)
|
| 2-ThiophenecarboxaMide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(Methylsulfonyl)phenyl]- |
|
1247825-37-1 |
詳細(xì)
|
| Pibrentasvir |
|
1353900-92-1 |
詳細(xì)
|
| HIF-2a Translation Inhibitor 76 |
|
882268-69-1 |
詳細(xì)
|
| 1-(4,4-DIPHENYL-3-BUTENYL)-3-PIPERIDINECARBOXYLIC ACID HYDROCHLORIDE |
|
85375-15-1 |
詳細(xì)
|
| 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
|
1338259-05-4 |
詳細(xì)
|
| Ertugliflozin L-pyroglutamic acid |
|
1210344-83-4 |
詳細(xì)
|
| VT-1161 |
|
1340593-59-0 |
詳細(xì)
|
| Duloxetine hydrochloride |
|
136434-34-9 |
詳細(xì)
|
| D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) |
|
2647441-36-7 |
詳細(xì)
|
| (S)-CFT7455 |
|
2504235-67-8 |
詳細(xì)
|
| Y-27632 dihydrochloride |
|
129830-38-2 |
詳細(xì)
|
| trace amine receptor 1 |
|
1043495-96-0 |
詳細(xì)
|
| Seletalisib |
|
1362850-20-1 |
詳細(xì)
|
| Licofelone |
|
156897-06-2 |
詳細(xì)
|
| Flumazenil |
|
78755-81-4 |
詳細(xì)
|
| (3aR)-2-Methyl-5α-(acetoxymethyl)-6β,7α-diacetoxy-3aα,6,7,7aα-tetrahydro-5H-pyrano[3,2-d]oxazole |
|
35954-65-5 |
詳細(xì)
|
| Safinamide mesylate |
|
202825-46-5 |
詳細(xì)
|
| AM 103 |
|
1147872-22-7 |
詳細(xì)
|
| Tolcapone |
|
134308-13-7 |
詳細(xì)
|
| Vanoxerine dihydrochloride |
|
67469-78-7 |
詳細(xì)
|
| HS-243 |
|
848249-10-5 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
|
2561414-56-8 |
詳細(xì)
|
| YTX-465 |
|
2225824-53-1 |
詳細(xì)
|
| 3-Thiophenecarboxylic acid, 2-amino-4-methyl-5-[[(3-nitrophenyl)amino]carbonyl]-, ethyl ester |
|
303141-21-1 |
詳細(xì)
|
| 1,8-Naphthyridine-2-nonanoic acid, 5,6,7,8-tetrahydro-α-[[(tetrahydro-4-methyl-2H-pyran-4-yl)carbonyl]amino]-, (αS)- |
|
2408065-32-5 |
詳細(xì)
|
| BPK-29 hydrochloride |
|
2444815-73-8 |
詳細(xì)
|
| SR 11237 |
|
146670-40-8 |
詳細(xì)
|
| 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxamide, 2-(1H-imidazol-1-yl)-N-[trans-4-(2-methoxyethoxy)cyclohexyl]- |
|
2597933-17-8 |
詳細(xì)
|
| Perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate |
|
160580-70-1 |
詳細(xì)
|
| 2-Propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- |
|
2505001-54-5 |
詳細(xì)
|
| Ro 60-0175 |
|
169675-08-5 |
詳細(xì)
|
| 2H-1-Benzopyran-6-carboxamide, 5-methoxy-N-[3-methoxy-4-[2-(2-piperidinyl)ethoxy]phenyl]-2,2-dimethyl- |
|
2411429-33-7 |
詳細(xì)
|
| (5Z)-2-hydroxy-4-methyl-6-oxo-5-[(5-phenylfuran-2-yl)methylidene]-5,6-dihydropyridine-3-carbonitrile |
|
591239-68-8 |
詳細(xì)
|
| 5-(N-(8-METHOXY-4-QUINOLYL)AMINO)PENTYL NITRATE |
|
47208-82-2 |
詳細(xì)
|
| (R)-N-(2-(1H-indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide hydrochloride |
|
925238-89-7 |
詳細(xì)
|
| Benzeneacetamide, α-[[6-(4-amino-1-piperidinyl)-3,5-dicyano-4-ethyl-2-pyridinyl]thio]- |
|
2170137-61-6 |
詳細(xì)
|
| 2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- |
|
1903742-34-6 |
詳細(xì)
|
| Necrosis Inhibitor, IM-54 |
|
861891-50-1 |
詳細(xì)
|
| HDAC-IN-40 |
|
2463198-51-6 |
詳細(xì)
|
| Hydroxyfasudil hydrochloride |
|
155558-32-0 |
詳細(xì)
|
| 2-Furancarboxamide, N-(4-hexylphenyl)-5-nitro- |
|
2244881-69-2 |
詳細(xì)
|
| 9-Azabicyclo[3.3.1]nonane-9-acetamide, N-(2-chlorophenyl)-3-[(3,4,5-trimethoxybenzoyl)amino]-, (3-exo)- |
|
2579689-83-9 |
詳細(xì)
|
| 1H-Pyrazole-3-carboxamide, 5-[1-[(4-fluorophenyl)methyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-N-(3-pyridinylmethyl)- |
|
1282606-48-7 |
詳細(xì)
|
| 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) |
|
2134096-06-1 |
詳細(xì)
|
| 2-Piperazinone, 1-(5-methyl-2-furanyl)-4-(1-oxo-2-propen-1-yl)- |
|
2094893-05-5 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
|
2743427-26-9 |
詳細(xì)
|
| LMI070 HCl |
|
1562338-39-9 |
詳細(xì)
|
| Hexanoic acid, 3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl]methyl]phenoxy]-, (3R)- |
|
2095128-20-2 |
詳細(xì)
|
| Pyrazino[2,1-c][1,2,4]thiadiazine, 9-[4-(cyclohexyloxy)phenyl]-3,4-dihydro-7-methyl-, 2,2-dioxide |
|
1358751-06-0 |
詳細(xì)
|
| 4-Piperidinol, 4-(aminomethyl)-1-[5-[2-methoxy-6-(1-methylethyl)-3-pyridinyl]imidazo[2,1-b]-1,3,4-thiadiazol-2-yl]- |
|
2640567-43-5 |
詳細(xì)
|